Although remdesivir has been hailed as a game changer by some, a clinical trial conducted in Wuhan, China, did not find any statistically meaningful difference in recovery for COVID-19 patients getting remdesivir infusions compared with patients receiving a placebo, and a large clinical trial twice changed the measure by which it judged the drug’s success […]
The new COVID-19 drug remdesivir is here. Now what? Dr. Powderly shares his thoughts in Science News.


















